Rifampin, MP Biomedicals™

Description

Inhibits DNA-dependent bacterial RNA polymerase. Rifampin, MP Biomedicals is a bactericidal antibiotic drug of the rifamycin group that does not affect mammalian RNA polymerase. It is used to treat Tuberculosis and Tuberculosis-related mycobacterial infec

Mode of Action: Inhibits initiation of RNA synthesis by binding to β-subunit of RNA polymerase. It inhibits the assembly of DNA and protein into mature virus particles.

• Treats Tuberculosis and Tuberculosis-related mycobacterial infections
• Widely used as an antipruritic agent in the autoimmune cholestatic liver disease, primary biliary cirrhosis (PBC)
• It has been shown to cause hepatitis

Specifications

Chemical Identifiers

• CAS: 13292-46-1
• Molecular Formula: C43H58N4O12
• Molecular Weight (g/mol): 822.953
• InChI Key: FZYOVNIOYYPUPY-HRJPTAQKSA-N
• Synonym: Rifamycin AMP, Rifampicin, 3-(4-Methylpiperazinyliminomethyl)rifamycin SV, Rifampicin
• PubChem CID: 131839595
• SMILES: CC1C=CC=C(C(=O)NC2=C(C3=C(C(=C4C(=C3C(=O)C2=CNN5CCN(CC5)C)C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C

• Physical Form: Powder
• Absorbance: λ max (methanol): 237–239, 334–338, 475–479nm
• Melting Point: 183°C to 188°C (decomposition)(literature)
• Extinction Coefficient: EmM (max absorbance, phosphate buffer, pH 7.38): 33.20 (237nm); 32.10 (255nm); 27.00 (334nm);15.40 (475nm) (Lit.)
• Quantity: 250 mg
• Optical Rotation: [α]D25°=+10.6° (c=0.5% in CDCl3)(Lit.)
• Solubility Information: Soluble in chloroform (349mg/mL, 25°C), DMSO (∽100mg/mL), ethyl acetate (108mg/mL, 25°C), methanol (16mg/mL, 25°C) tetrahydrofuran.
• Formula Weight: 822.96

Safety and Handling

Recommended Storage

+4°C

WARNING: Reproductive Harm - www.P65Warnings.ca.gov